Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-18 Sale |
2025-03-20 9:49 pm |
Tarsus Pharmaceuticals Inc. | TARS | Wahl Bryan General Counsel |
9,686 | $47.88 | $463,766 | 51,712 (Direct) |
View |
| 2024-03-18 Sale |
2024-03-19 7:05 pm |
Tarsus Pharmaceuticals Inc. | TARS | Wahl Bryan General Counsel |
4,436 | $30.6 | $135,742 | 72,276 (Direct) |
View |
| 2023-11-30 Sale |
2023-12-01 4:55 pm |
Tarsus Pharmaceuticals Inc. | TARS | Wahl Bryan General Counsel |
8,356 | $16.31 | $136,286 | 31,966 (Direct) |
View |
| 2023-03-21 Sale |
2023-03-23 7:52 pm |
Tarsus Pharmaceuticals Inc. | TARS | Wahl Bryan General Counsel |
1,078 | $12.55 | $13,532 | 16,402 (Direct) |
View |
| 2023-03-17 Sale |
2023-03-21 7:14 pm |
Tarsus Pharmaceuticals Inc. | TARS | Wahl Bryan General Counsel |
696 | $12.94 | $9,004 | 17,480 (Direct) |
View |
| 2023-03-16 Sale |
2023-03-17 6:21 pm |
Tarsus Pharmaceuticals Inc. | TARS | Wahl Bryan General Counsel |
337 | $13.43 | $4,526 | 32,546 (Direct) |
View |
| 2022-12-02 Sale |
2022-12-06 5:49 pm |
Tarsus Pharmaceuticals Inc. | TARS | Wahl Bryan General Counsel |
1,154 | $16.9 | $19,503 | 13,723 (Direct) |
View |
| 2022-11-30 Sale |
2022-12-01 7:58 pm |
Tarsus Pharmaceuticals Inc. | TARS | Wahl Bryan General Counsel |
2,347 | $16.62 | $39,017 | 38,797 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-15 Exercise |
2025-03-18 9:39 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | Wahl Bryan General Counsel |
38,426 | $0 | 102,212 (Direct) |
View |
| 2025-03-05 Option Award |
2025-03-07 4:18 pm |
N/A 2035-03-04 |
Tarsus Pharmaceuticals Inc. | TARS | Wahl Bryan General Counsel |
50,717 | $0 | 50,717 (Direct) |
View |
| 2024-03-15 Exercise |
2024-03-19 7:05 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | Wahl Bryan General Counsel |
24,076 | $0 | 72,276 (Direct) |
View |
| 2024-03-07 Option Award |
2024-03-11 5:45 pm |
N/A 2034-03-06 |
Tarsus Pharmaceuticals Inc. | TARS | Wahl Bryan General Counsel |
71,202 | $0 | 71,202 (Direct) |
View |
| 2023-11-29 Exercise |
2023-12-01 4:55 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | Wahl Bryan General Counsel |
23,920 | $0 | 31,966 (Direct) |
View |
| 2023-03-15 Exercise |
2023-03-17 6:21 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | Wahl Bryan General Counsel |
4,790 | $0 | 32,546 (Direct) |
View |
| 2023-03-08 Option Award |
2023-03-10 7:29 pm |
N/A 2033-03-08 |
Tarsus Pharmaceuticals Inc. | TARS | Wahl Bryan General Counsel |
71,795 | $0 | 71,795 (Direct) |
View |
| 2022-11-29 Exercise |
2022-12-01 7:58 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | Wahl Bryan General Counsel |
10,251 | $0 | 38,797 (Direct) |
View |
| 2022-03-09 Option Award |
2022-03-11 4:15 pm |
N/A 2032-03-08 |
Tarsus Pharmaceuticals Inc. | TARS | Wahl Bryan General Counsel |
118,643 | $0 | 118,643 (Direct) |
View |
| 2021-02-02 Option Award |
2021-02-02 7:57 pm |
N/A 2031-02-02 |
Tarsus Pharmaceuticals Inc. | TARS | Wahl Bryan General Counsel |
89,368 | $0 | 89,368 (Direct) |
View |
Ownership |
2021-01-21 1:24 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | Wahl Bryan General Counsel |
0 | $0 | 5,000 (Direct) |
View |